06
Sep
2017
Second issue of shares completed in July
Ectin research second issue of shares amounting to a value of 1.5 million SEK was completed in July…
Read moreNews
22
Feb
2017
Prestigious SME Instrument Horizon 2020 funding granted
Ectin Research has been selected by the European Commission as the winner of HORIZON 2020 “Phase 1” –…
Read more
23
Dec
2016
Västra götalandsregionen supports Ectin research
The company was recently granted additional “Såddfinansiering” to support the development of bladder cancer therapy.
Read more
26
Oct
2016
Ectin Research attends BIO-Europe November 7-9
Meet the company at BIO-Europe, one of the main events for partnering and drug development, this year in…
Read more
22
Jun
2016
VINNOVA grants business developmental support (“SME-verifieringsmedel”)
VINNOVA through Sahlgrenska Science Park supports Ectin Research business developmental activities by rewarding the company 100 000 SEK…
Read more
13
Apr
2016
MFA-370 against severe bladder cancer enters next developmental phase
Next phase of product development of MFA-370 against severe bladder cancer is initiated by Ectin research. An experienced…
Read more
26
Feb
2016
New share issue completed
Ectin research first issue of shares amounting to a value of 3 million SEK is completed and the…
Read more
15
Oct
2015
Ectin Research appoints new chairman
The company announces the appointment of Michael Oredsson as chairman of Ectin Research. He is currently CEO of…
Read more
18
Jun
2015
Västra götalandsregionen grants additional support to Ectin Research
“Såddfinansiering” was granted to the company to support the company’s development of bladder cancer therapy.
Read more
19
Nov
2014
Västra götalandsregionen supports Ectin Research
“Konsultcheck” was granted to the company to conduct external evaluation of the pre-clinical toxicology regarding the company’s technology.
Read more